Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 2Leukemia, Myeloid, Acute 2Epstein-Barr Virus Infections 2Cytomegalovirus Infections 2Colorectal Neoplasms 2Adenoviridae Infections 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Papillomavirus Infections 1Ovarian Neoplasms 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Nasopharyngeal Carcinoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Hematologic Neoplasms 1

Interventions

fludarabine phosphate 4Whole-Body Irradiation 4Cyclophosphamide 3Blood Specimen Collection 3Antilymphocyte Serum 3Alemtuzumab 3plerixafor 2Thiotepa 2Therapeutics 2Melphalan 2Cyclosporins 2Cyclosporine 2Busulfan 2thymoglobulin 1fosphenytoin 1fludarabine 1Voriconazole 1Vaccination 1Tacrolimus 1Photopheresis 1Phlebotomy 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Injections 1Holistic Health 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Exercise 1Clinical Trials, Phase I as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Immunologic Deficiency Syndromes × Cell Count × Clear all
NCT06926894 2025-07-31

R-MVST Cells for Treatment of Viral Infections in Children and Young Adults

Columbia University

Phase 1 Recruiting
18 enrolled

Adenoviridae Infections, Cytomegalovirus Infections, Immunologic Deficiency Syndromes, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡